Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    NGM Biopharmaceuticals In...

    NASDAQ: NGM · Real-Time Price · USD
    1.54
    -0.02 (-1.28%)
    At close: Apr 03, 2024, 3:59 PM

    NGM Biopharmaceuticals Cash Flow Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Net Income
    		 -142.38M -162.67M -120.33M
    Depreciation & Amortization
    		 2.22M 4.04M 6.09M
    Stock-Based Compensation
    		 28.72M 32.38M 26.24M
    Other Working Capital
    		 -20.92M -23.92M 8.63M
    Other Non-Cash Items
    		 -7.37M 2.52M 7.05M
    Deferred Income Tax
    		 4.98M n/a 3.51M
    Change in Working Capital
    		 -18.38M -20.71M 4.21M
    Operating Cash Flow
    		 -132.2M -144.44M -73.23M
    Capital Expenditures
    		 -1.25M -1.86M -1.68M
    Cash Acquisitions
    		 n/a -16.18M 69.97M
    Purchase of Investments
    		 -105.43M -272.86M -293.47M
    Sales Maturities Of Investments
    		 220.97M 289.04M 223.5M
    Other Investing Acitivies
    		 n/a 16.18M -69.97M
    Investing Cash Flow
    		 114.29M 14.32M -71.65M
    Debt Repayment
    		 n/a n/a n/a
    Common Stock Repurchased
    		 n/a n/a n/a
    Dividend Paid
    		 n/a n/a n/a
    Other Financial Acitivies
    		 1.77M 54.23M 149.66M
    Financial Cash Flow
    		 1.77M 54.23M 149.66M
    Net Cash Flow
    		 -14.64M -75.88M 4.78M
    Free Cash Flow
    		 -133.45M -146.3M -74.91M

    Add to Watchlist